# US 2022/0031377 A1 · Systems and Methods for Lesion Formation and Assessment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031377 A1
- Document ID: US20220031377A1
- Status: Published application
- Kind: A1
- Application number: 17/387,915
- Filed: 2021-07-28
- Published: 2022-02-03
- Earliest claimed: 2020-07-28
- Assignees: 460Medical, Inc.
- Applicants: 460Medical, Inc.
- Inventors: Terrance J. Ransbury; Omar Amirana
- Web page: https://patentgrep.com/patent/US20220031377A1

## CPC

- A61B 18/00: Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body (eye surgery A61F9/007; ear surgery A61F11/00)
- A61B 1/0011: {Manufacturing of endoscope parts}
- A61B 1/00165: {with light-conductive means, e.g. fibre optics (A61B1/07 takes precedence)}
- A61B 1/00181: {for multiple fixed viewing angles (A61B1/00193 takes precedence)}
- A61B 1/042: {characterised by a proximal camera, e.g. a CCD camera}
- A61B 1/043: {for fluorescence imaging}
- A61B 1/0625: {for multiple fixed illumination angles}
- A61B 1/063: {for monochromatic or narrow-band illumination}
- A61B 1/0638: {providing two or more wavelengths}
- A61B 1/0669: {at proximal end of an endoscope}
- A61B 1/07: using light-conductive means, e.g. optical fibres
- A61B 5/0036: {including treatment, e.g., using an implantable medical device, ablating, ventilating}
- A61B 5/0044: {for the heart}
- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1459: invasive, e.g. introduced into the body by a catheter
- A61B 5/6852: {Catheters}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 8/4416: {related to combined acquisition of different diagnostic modalities, e.g. combination of ultrasound and X-ray acquisitions}
- A61B 8/445: {Details of catheter construction}
- A61B 2018/00434: {Neural system}
- A61B 2018/00511: {Kidney}
- A61B 2018/00577: {Ablation}
- A61B 2018/00904: {Automatic detection of target tissue}
- A61B 2018/00982: {combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes}
- A61B 2562/0204: Acoustic sensors
- A61B 2562/0271: Thermal or temperature sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

System and methods for optical tissue interrogation are provided. In some embodiments, a catheter for visualizing ablated tissue is provided, and can include a catheter body, and a distal tip positioned at a distal end of the catheter body. The distal tip can have one or more openings for exchange of light energy between the distal tip of the catheter and tissue.

## Claims

### Claim 1

A catheter for visualizing ablated tissue comprising:
a catheter body;
a distal tip positioned at a distal end of the catheter body, the distal tip having one or more ports for an exchange of light energy between the distal tip and tissue;
a lumen extending through the catheter body and the distal tip and having one more openings corresponding to the one or more ports on the distal tip; and
one or more optical fibers configured to extend through the lumen and the one or more openings to an outer surface of the distal tip through one or more ports in the distal tip such that the one or more optical fibers direct the light energy to and from the tissue through the one or more ports.

### Claim 2 (depends on 1)

The catheter of claim 1, further comprising one or more channels configured to connect the one or more openings in the lumen to the one or more ports of the distal tip to direct the one or more optical fibers to the outer surface of the distal tip.

### Claim 3 (depends on 1)

The catheter of claim 1, wherein the one or more ports are disposed circumferentially along the distal tip and are spaced apart from one another by equal distance.

### Claim 4 (depends on 1)

The catheter of claim 1, wherein one of the one or more ports is disposed at a distal end of the distal tip to direct light to tissue in front of the distal tip.

### Claim 5 (depends on 1)

The catheter of claim 1, wherein the one or more fibers are fixedly coupled to the one or more ports in the distal tip.

### Claim 6 (depends on 1)

The catheter of claim 1, wherein the distal tip is configured to deliver ablation energy to the tissue.

### Claim 7 (depends on 6)

The catheter of claim 6, wherein the ablation energy is selected from a group consisting of radiofrequency (RF) energy, microwave energy, electrical energy, electromagnetic energy, cryoenergy, laser energy, ultrasound energy, acoustic energy, chemical energy, thermal energy and combinations thereof.

### Claim 8 (depends on 1)

The catheter of claim 1, wherein the light for illuminating the tissue has at least one wavelength between about 300 nm and about 400 nm.

### Claim 9 (depends on 1)

The catheter of claim 1, wherein the tissue is selected from a group consisting of skeletal muscle, liver, pancreas, brain, neural tissue, spleen, breast, uterus, cervical, prostate, bladder, esophagus, lung, pulmonary, arterial, blood clot or hematologic, gastrointestinal tract, adrenals, ovaries, testicles, genitourinary, and kidney.

### Claim 10

A system for visualizing ablated tissue comprising:
a catheter comprising a catheter body; a distal tip positioned at a distal end of the catheter body, the distal tip having one or more ports for exchange of light energy between the distal tip and tissue; a lumen extending through the catheter body and the distal tip and having one more openings corresponding to the one or more ports on the distal tip; and one or more optical fibers configured to extend through the lumen and the one or more openings to an outer surface of the distal tip through one or more ports in the distal tip such that the one or more optical fibers direct the light energy to and from the tissue through the one or more ports;
a light source;
a light measuring instrument; and
one or more optical fibers in communication with the light source and the light measuring instrument and extending through the catheter body into the distal tip, wherein the one or more optical fibers are configured to pass light energy from the light source to the light directing member for illuminating tissue outside the distal tip and the one or more optical fibers are configured to relay light energy reflected from the tissue to the light measuring instrument.

### Claim 11 (depends on 10)

The system of claim 10, wherein the one or more ports are disposed circumferentially along the distal tip and are spaced apart from one another by equal distance.

### Claim 12 (depends on 10)

The system of claim 10, further comprising an ultrasound transducer.

### Claim 13 (depends on 10)

The system of claim 10, further comprising a source of ablation energy in communication with the distal tip to deliver ablation energy to the tissue,

### Claim 14 (depends on 13)

The system of claim 13, wherein the ablation energy is selected from a group consisting of radiofrequency (RF) energy, microwave energy, electrical energy, electromagnetic energy, cryoenergy, laser energy, ultrasound energy, acoustic energy, chemical energy, thermal energy and combinations thereof.

### Claim 15 (depends on 10)

The system of claim 10, wherein the light for illuminating the tissue has at least one wavelength between about 300 nm and about 400 nm.

### Claim 16 (depends on 10)

The system of claim 10, wherein the light measuring instrument is configured to detect returned light having a wavelength between about 450 nm and 470 nm is monitored.

### Claim 17

A method for visualizing ablated tissue comprising:
advancing a catheter to a cardiac tissue in need of ablation, the catheter comprising a catheter body; a distal tip positioned at a distal end of the catheter body, the distal tip having one or more ports for exchange of light energy between the distal tip and tissue; a lumen extending through the catheter body and the distal tip and having one more openings corresponding to the one or more ports on the distal tip; and one or more optical fibers configured to extend through the lumen and the one or more openings to an outer surface of the distal tip through one or more ports in the distal tip such that the one or more optical fibers direct the light energy to and from the tissue through the one or more ports;
illuminated the tissue through the one or more ports in the distal tip of the catheter to excite nicotinamide adenine dinucleotide hydrogen (NADH) in an area of the tissue including ablated cardiac tissue and non-ablated tissue;
collecting light reflected from the tissue through the one or more openings and directing the collected light to a light measuring instrument;
imaging the area of the tissue to detect NADH fluorescence of the area of the cardiac tissue; and
producing a display of the imaged, illuminated tissue, the display illustrating the ablated cardiac tissue as having less fluorescence than non-ablated tissue.

### Claim 18 (depends on 17)

The method of claim 17, further comprising ablating tissue with the distal tip prior to imaging the tissue.

### Claim 19 (depends on 18)

The method of claim 18, further comprising ablating additional non-ablated tissue identified by distinguishing between the ablated tissue and the non-ablated tissue based on the amount of fluorescence.

### Claim 20 (depends on 17)

The method of claim 17, wherein the tissue is selected from a group consisting of skeletal muscle, liver, pancreas, brain, neural tissue, spleen, breast, uterus, cervical, prostate, bladder, esophagus, lung, pulmonary, arterial, blood clot or hematologic, gastrointestinal tract, adrenals, ovaries, testicles, genitourinary, and kidney.
